FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

B Braun Medical Dextrose Injection Recall

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B

B BRAUN MEDICAL INC · Allentown, PA

Risk level
Class II
Reported by FDA
Apr 29, 2026
Recall ID
D-0496-2026
Check your lot numberHow we source this data

Summary

B Braun Medical recalled Dextrose Injection starting Apr 2, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0496-2026 on Apr 29, 2026. Reason: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Product description

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.

Lot numbers, UPCs & expiration codes

Lot # J5H166, J5H167, Exp Date: 30NOV2026.

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0496-2026
Classification
Class II
Status
Ongoing
Recall initiated
Apr 2, 2026
FDA report date
Apr 29, 2026
Quantity
17,124 bags
Recall type
Voluntary: Firm initiated
Recalling firm
B BRAUN MEDICAL INC

Original FDA data

Every field from FDA enforcement report D-0496-2026, exactly as published.

Show all FDA fields
City
Allentown
State
PA
Status
Ongoing
Country
United States
Event ID
98693
Address
861 Marcon Blvd
Code information
Lot # J5H166, J5H167, Exp Date: 30NOV2026.
Postal code
18109-9577
Report date
Apr 29, 2026
Product type
Drugs
Recall number
D-0496-2026
Classification
Class II
Recalling firm
B BRAUN MEDICAL INC
Product quantity
17,124 bags
Reason for recall
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Voluntary / mandated
Voluntary: Firm initiated
Product description
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
Distribution pattern
US Nationwide.
Recall initiation date
Apr 2, 2026
Initial firm notification
Letter
Center classification date
Apr 28, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0496-2026, published Apr 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls